These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23334923)

  • 1. Cost-effectiveness of school support for orphan girls to prevent HIV infection in Zimbabwe.
    Miller T; Hallfors D; Cho H; Luseno W; Waehrer G
    Prev Sci; 2013 Oct; 14(5):503-12. PubMed ID: 23334923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of an intervention to reduce HIV/STI incidence and promote condom use among female sex workers in the Mexico-US border region.
    Burgos JL; Gaebler JA; Strathdee SA; Lozada R; Staines H; Patterson TL
    PLoS One; 2010 Jun; 5(6):e11413. PubMed ID: 20617193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.
    Juusola JL; Brandeau ML; Owens DK; Bendavid E
    Ann Intern Med; 2012 Apr; 156(8):541-50. PubMed ID: 22508731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing HIV by providing support for orphan girls to stay in school: does religion matter?
    Hallfors DD; Cho H; Iritani BJ; Mapfumo J; Mpofu E; Luseno WK; January J
    Ethn Health; 2013; 18(1):53-65. PubMed ID: 22715988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supporting adolescent orphan girls to stay in school as HIV risk prevention: evidence from a randomized controlled trial in Zimbabwe.
    Hallfors D; Cho H; Rusakaniko S; Iritani B; Mapfumo J; Halpern C
    Am J Public Health; 2011 Jun; 101(6):1082-8. PubMed ID: 21493943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
    Mafirakureva N; Mapako T; Khoza S; Emmanuel JC; Marowa L; Mvere D; Postma MJ; van Hulst M
    Transfusion; 2016 Dec; 56(12):3101-3111. PubMed ID: 27696441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
    Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
    PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and cost-effectiveness of a mental health intervention for war-affected young persons: decision analysis based on a randomized controlled trial.
    McBain RK; Salhi C; Hann K; Salomon JA; Kim JJ; Betancourt TS
    Health Policy Plan; 2016 May; 31(4):415-24. PubMed ID: 26345320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
    Ryan M; Griffin S; Chitah B; Walker AS; Mulenga V; Kalolo D; Hawkins N; Merry C; Barry MG; Chintu C; Sculpher MJ; Gibb DM
    AIDS; 2008 Mar; 22(6):749-57. PubMed ID: 18356605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of the Mpowerment Project, a community-level intervention for young gay men.
    Kahn JG; Kegeles SM; Hays R; Beltzer N
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):482-91. PubMed ID: 11511826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of darunavir/ritonavir in highly treatment-experienced, HIV-1-infected adults in the USA.
    Mauskopf J; Brogan A; Martin S; Smets E
    Pharmacoeconomics; 2010; 28 Suppl 1():83-105. PubMed ID: 21182346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
    Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
    Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, HIV-infected adults with evidence of protease inhibitor resistance included in the TITAN Trial.
    Brogan A; Mauskopf J; Talbird SE; Smets E
    Pharmacoeconomics; 2010; 28 Suppl 1():129-46. PubMed ID: 21182348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male circumcision at different ages in Rwanda: a cost-effectiveness study.
    Binagwaho A; Pegurri E; Muita J; Bertozzi S
    PLoS Med; 2010 Jan; 7(1):e1000211. PubMed ID: 20098721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa.
    Walker SM; Cox E; Revill P; Musiime V; Bwakura-Dangarembizi M; Mallewa J; Cheruiyot P; Maitland K; Ford N; Gibb DM; Walker AS; Soares M;
    J Int AIDS Soc; 2020 Mar; 23(3):e25469. PubMed ID: 32219991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Needle exchange programs are a cost-effective preventative measure against HIV in Iceland].
    Eythórsson ES; Ásgeirsdóttir TL; Gottfređsson M
    Laeknabladid; 2014 Jul; 100(7-8):379-83. PubMed ID: 25125435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of a modestly effective HIV vaccine in the United States.
    Long EF; Owens DK
    Vaccine; 2011 Aug; 29(36):6113-24. PubMed ID: 21510996
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.